908761918	908761918	CD	B-NP	O
|	|	NN	I-NP	O
MMC	MMC	NN	I-NP	O
|	|	NN	I-NP	O
45427009	45427009	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0927689	0927689	CD	B-NP	O
|	|	CC	I-NP	O
5/26/2007	5/26/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
ATRIAL	ATRIAL	NN	I-NP	O
FIBRILLATION	FIBRILLATION	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

ENDOCARDITIS	ENDOCARDITIS	NNP	B-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/21/2007	2/21/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/29/2007	9/29/2007	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SALAZAN	SALAZAN	NNP	B-NP	O
,	,	,	O	O
SHELDON	SHELDON	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Clare	Clare	NNP	B-NP	O
`	`	``	O	O
squette	squette	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Bacteremia	Bacteremia	NN	B-NP	O
,	,	,	O	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
AND	AND	CC	O	O
DIAGNOSES	DIAGNOSES	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
hemorrhagic	hemorrhagic	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

BPH	BPH	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
pubic	pubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
including	include	VBG	B-PP	O
recent	recent	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
on	on	IN	B-PP	O
4/2	4/2	CD	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
slow	slow	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
from	from	IN	B-PP	O
rehab	rehab	NN	B-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
following	follow	VBG	B-PP	O
a	a	DT	B-NP	O
Burgworth-hend	Burgworth-hend	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
admission	admission	NN	I-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
spiked	spike	VBD	B-VP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
growing	grow	VBG	B-VP	O
out	out	RP	B-PRT	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
urinalysis	urinalysis	NN	I-NP	I-protein
at	at	IN	B-PP	I-protein
rehab	rehab	NN	B-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
two	two	CD	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
ciprofloxacin	ciprofloxacin	NN	B-NP	O
for	for	IN	B-PP	O
positive	positive	JJ	B-NP	O
UA	UA	NN	I-NP	O
and	and	CC	O	O
admitted	admit	VBN	B-VP	O
to	to	TO	B-PP	O
Kootema	Kootema	NNP	B-NP	O
General	General	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
and	and	CC	O	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
recent	recent	JJ	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
review	review	NN	B-NP	O
of	of	IN	B-PP	O
systems	system	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
URI	URI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
rash	rash	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	I-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	I-NP	O
sweats	sweat	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
and	and	CC	O	O
overall	overall	JJ	B-NP	O
reports	report	NNS	I-NP	O
feeling	feel	VBG	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
4/10	4/10	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hyperlipidemia	Hyperlipidemia	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
slow	slow	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Anemia	Anemia	NNP	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
hemorrhagic	hemorrhagic	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

BPH	BPH	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
placement	placement	NN	I-NP	O
during	during	IN	B-PP	O
AVR	AVR	NN	B-NP	O
surgery	surgery	NN	I-NP	O
in	in	IN	B-PP	O
4/10	4/10	CD	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	B-protein
nebulizers	nebulizer	NNS	I-NP	I-protein
2.5	2.5	CD	B-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.	q.	RB	B-NP	I-protein
12	12	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Sarna	Sarna	NNP	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Ciprofloxacin	Ciprofloxacin	NN	B-NP	O
250	250	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
two	two	CD	B-NP	O
doses	dose	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Fluticasone	Fluticasone	NN	B-NP	O
one	one	CD	I-NP	O
spray	spray	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
nostril	nostril	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	B-protein
80	80	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

Flovent	Flovent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	B-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Subcutaneous	Subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lispro	Lispro	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
32	32	CD	I-NP	O
units	unit	NNS	I-NP	O
nightly	nightly	RB	B-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
wheezing	wheezing	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Tylenol	Tylenol	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	VBP	B-VP	O
b.i.d.	b.i.d.	RB	B-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Losartan	Losartan	RB	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
chloride	chloride	NN	I-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.	q.	RB	B-NP	O
12	12	CD	I-NP	O
h.	h.	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

Maalox	Maalox	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Dulcolax	Dulcolax	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

23	23	CD	B-NP	O
.	.	.	O	O

Benadryl	Benadryl	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

24	24	CD	B-NP	O
.	.	.	O	O

MiraLax	MiraLax	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Sulfa	Sulfa	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
swelling	swell	VBG	B-VP	O
-RRB-	-RRB-	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Tetracycline	Tetracycline	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
swelling	swell	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
remote	remote	JJ	I-NP	O
tobacco	tobacco	NN	I-NP	O
history	history	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
40-pack-year	40-pack-year	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
quit	quit	VBD	B-VP	O
40	40	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
walker	walker	NN	I-NP	O
and	and	CC	I-NP	O
wheelchair	wheelchair	NN	I-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
PHYSICAL	PHYSICAL	NN	I-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
:	:	:	O	O
Vital	Vital	JJ	B-NP	O
signs	sign	NNS	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	B-protein
98.5	98.5	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
49	49	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
160/56	160/56	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18	18	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
94.3	94.3	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

General	General	JJ	B-NP	O
appearance	appearance	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
at	at	IN	B-PP	O
present	present	NN	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Oropharynx	Oropharynx	NNP	B-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
palatal	palatal	JJ	I-NP	O
petechiae	petechiae	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
are	be	VBP	B-VP	O
equally	equally	RB	B-ADJP	O
round	round	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
reactive	reactive	JJ	I-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
and	and	CC	I-NP	O
accommodation	accommodation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
scleral	scleral	JJ	I-NP	O
icterus	icterus	NN	I-NP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Neck	Neck	NNP	B-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
or	or	CC	I-NP	O
masses	mass	NNS	I-NP	O
present	present	VBP	B-VP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Rate	Rate	NNP	B-NP	O
is	be	VBZ	B-VP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
that	that	WDT	B-NP	O
is	be	VBZ	B-VP	O
heard	hear	VBN	I-VP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

Jugular	Jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
distended	distend	VBN	I-VP	O
and	and	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
seen	see	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ear	ear	NN	I-NP	B-protein
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
bilateral	bilateral	JJ	B-NP	O
basilar	basilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
positive	positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	I-ADJP	O
nondistended	nondistended	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
nontender	nontender	JJ	I-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
rebound	rebound	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
no	no	DT	B-NP	O
stigmata	stigmata	NN	I-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
splinter	splinter	NN	I-NP	O
hemorrhages	hemorrhage	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
Osler	Osler	NNP	I-NP	O
nodes	node	NNS	I-NP	O
or	or	CC	O	O
red	red	JJ	B-NP	O
spots	spot	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bilateral	bilateral	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
1	1	CD	B-NP	O
+	+	JJ	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	I-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
nonfocal	nonfocal	JJ	B-ADJP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
sodium	sodium	NN	B-NP	O
144	144	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.5	4.5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
106	106	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
30	30	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
41	41	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.9	1.9	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
83	83	CD	I-NP	I-protein
,	,	,	O	O
anion	anion	NN	B-NP	O
gap	gap	NN	I-NP	O
is	be	VBZ	B-VP	O
8	8	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
8.1	8.1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
31.7	31.7	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
332	332	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
71	71	CD	B-NP	O
%	%	NN	I-NP	O
neutrophils	neutrophil	NNS	I-NP	O
,	,	,	O	O
14	14	CD	B-NP	O
%	%	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
and	and	CC	O	O
12	12	CD	B-NP	O
%	%	NN	I-NP	O
monocytes	monocyte	NNS	I-NP	O
.	.	.	O	O

Calcium	Calcium	NNP	B-NP	O
is	be	VBZ	B-VP	O
8.7	8.7	CD	B-NP	O
.	.	.	O	O

Urinalysis	Urinalysis	NN	B-NP	O
shows	show	VBZ	B-VP	O
trace	trace	NN	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
leukocyte	leukocyte	NN	I-NP	B-protein
esterase	esterase	NN	I-NP	I-protein
.	.	.	O	O

40-50	40-50	CD	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
1-5	1-5	CD	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
bacteria	bacteria	NNS	I-NP	O
.	.	.	O	O

STUDIES	STUDIES	NNS	B-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
ADMISSION	ADMISSION	NN	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
shows	show	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
midline	midline	NN	I-NP	O
sternotomy	sternotomy	NN	I-NP	O
and	and	CC	I-NP	O
CABG	CABG	NN	I-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
silhouette	silhouette	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
x-rays	x-ray	NNS	I-NP	O
.	.	.	O	O

Right	Right	NN	B-NP	O
lung	lung	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
left	left	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
reduced	reduce	VBN	I-VP	O
in	in	IN	B-PP	O
size	size	NN	B-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
x-ray	x-ray	NN	I-NP	O
dated	date	VBN	B-VP	O
8/29/07	8/29/07	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
irregularly	irregularly	RB	I-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
44	44	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
left	left	JJ	B-NP	O
axis	axis	NN	I-NP	O
deviation	deviation	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
bundle-branch	bundle-branch	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	I-NP	O
Q	Q	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
in	in	IN	B-PP	O
5/3	5/3	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
82-year-old	82-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
most	most	RBS	B-ADVP	O
significantly	significantly	RB	I-ADVP	O
including	include	VBG	B-PP	O
recent	recent	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
slow	slow	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
response	response	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
and	and	CC	O	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
with	with	IN	B-PP	O
concerns	concern	NNS	B-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	B-protein
given	give	VBN	B-VP	I-protein
his	his	PRP$	B-NP	I-protein
recent	recent	JJ	I-NP	I-protein
AVR	AVR	NN	I-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
vancomycin	vancomycin	NN	I-NP	O
empirically	empirically	RB	B-ADVP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
two	two	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	B-PP	O
two	two	CD	B-NP	O
bottles	bottle	NNS	I-NP	O
of	of	IN	B-PP	O
Gemella	Gemella	NN	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
.	.	.	O	O

Urinary	Urinary	JJ	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
10	10	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
colonies	colony	NNS	I-NP	O
of	of	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
aeruginosa	aeruginosa	NN	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
taken	take	VBN	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
wound	wound	NN	I-NP	O
site	site	NN	I-NP	O
and	and	CC	O	O
revealed	reveal	VBD	B-VP	O
rare	rare	JJ	B-NP	O
MRSA	MRSA	NN	I-NP	O
,	,	,	O	O
few	few	JJ	B-NP	O
coag-negative	coag-negative	JJ	I-NP	O
staph	staph	NN	I-NP	O
and	and	CC	O	O
rare	rare	JJ	B-NP	O
enterococci	enterococci	NNS	I-NP	O
.	.	.	O	O

Once	Once	IN	B-SBAR	O
blood	blood	NN	B-NP	O
cultures	culture	NNS	I-NP	O
for	for	IN	B-PP	O
Gemella	Gemella	NN	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
returned	return	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	I-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
on	on	IN	B-PP	O
7/17/07	7/17/07	CD	B-NP	O
.	.	.	O	O

Ceftazidime	Ceftazidime	NN	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
as	as	IN	B-SBAR	O
was	be	VBD	B-VP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
while	while	IN	B-SBAR	O
inhouse	inhouse	NN	B-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
exhibit	exhibit	VB	I-VP	O
any	any	DT	B-NP	O
significant	significant	JJ	I-NP	O
leukocytosis	leukocytosis	NN	I-NP	O
or	or	CC	I-NP	O
stigmata	stigma	NNS	I-NP	O
of	of	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

Surveillance	Surveillance	NN	B-NP	O
cultures	culture	NNS	I-NP	O
obtained	obtain	VBN	B-VP	O
after	after	IN	B-PP	O
starting	start	VBG	B-VP	O
antibiotics	antibiotic	NNS	B-NP	O
have	have	VBP	B-VP	O
remained	remain	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
TTE	TTE	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
valvular	valvular	JJ	I-NP	O
vegetation	vegetation	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	B-protein
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
any	any	DT	B-NP	O
ring	ring	NN	I-NP	O
abscess	abscess	NN	I-NP	O
or	or	CC	O	O
valvular	valvular	JJ	B-NP	O
vegetation	vegetation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	O	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
CAD	CAD	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
full	full	JJ	I-NP	O
strength	strength	NN	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBN	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
appeared	appear	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
gradually	gradually	RB	I-VP	O
became	become	VBD	I-VP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
given	give	VBN	I-VP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
restarted	restart	VBD	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
QAM	QAM	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
slightly	slightly	RB	B-NP	O
volume	volume	NN	I-NP	O
overloaded	overload	VBN	B-VP	O
,	,	,	O	O
but	but	CC	O	O
diuresing	diurese	VBG	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Losartan	Losartan	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	I-NP	O
initiation	initiation	NN	I-NP	O
of	of	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
96.6	96.6	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
I/O	I/O	NN	I-NP	O
goal	goal	NN	I-NP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
is	be	VBZ	B-VP	O
500cc	500cc	CD	B-NP	O
negative	negative	JJ	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
93	93	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
's	's	POS	B-NP	O
lasix	lasix	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
as	as	IN	B-SBAR	O
he	he	PRP	B-NP	O
reaches	reach	VBZ	B-VP	O
his	his	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
bradycardic	bradycardic	JJ	B-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
down	down	IN	B-ADVP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
mid-to-low	mid-to-low	JJ	I-NP	O
30s	30	NNS	I-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
refused	refuse	VBD	B-VP	O
permanent	permanent	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
nodal	nodal	JJ	I-NP	O
agents	agent	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
avoided	avoid	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
several	several	JJ	B-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
nonsustained	nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
upto	upto	IN	B-PP	O
14	14	CD	B-NP	O
beats	beat	NNS	I-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
magnesium	magnesium	NN	B-NP	O
above	above	IN	B-PP	O
2	2	CD	B-NP	O
and	and	CC	O	O
potassium	potassium	NN	B-NP	O
above	above	IN	B-PP	O
4	4	CD	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
medical	medical	JJ	I-NP	O
management	management	NN	I-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
bradycardia	bradycardia	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
high	high	JJ	B-NP	O
suspicion	suspicion	NN	I-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
AVR	AVR	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
Gemella	Gemella	NN	B-NP	O
morbillorum	morbillorum	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
as	as	IN	B-SBAR	O
noted	note	VBN	B-VP	O
above	above	RB	B-ADVP	O
empirically	empirically	RB	I-ADVP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	I-NP	O
ceftazidime	ceftazidime	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
changed	change	VBD	B-VP	O
to	to	TO	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	I-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
on	on	IN	B-PP	O
7/17/07	7/17/07	CD	B-NP	O
once	once	RB	I-NP	O
gram-positive	gram-positive	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
were	be	VBD	B-VP	O
speciated	speciate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
pseudomonal	pseudomonal	JJ	B-NP	O
UTI	UTI	NN	I-NP	O
with	with	IN	B-PP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
only	only	RB	B-NP	O
10000	10000	CD	I-NP	O
CFUs	CFU	NNS	I-NP	O
grew	grow	VBD	B-VP	O
out	out	RP	B-PRT	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
ceftazidime	ceftazidime	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
some	some	DT	B-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
plus	plus	CC	I-NP	O
gentamicin	gentamicin	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
7/17/07	7/17/07	CD	B-NP	O
for	for	IN	B-PP	O
continued	continue	VBN	B-NP	O
IV	IV	CD	I-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
and	and	CC	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
a	a	DT	B-NP	O
two-week	two-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
endocarditis	endocarditis	NN	I-NP	O
despite	despite	IN	B-PP	O
both	both	CC	O	O
negative	negative	JJ	B-NP	O
transthoracic	transthoracic	JJ	I-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
and	and	CC	O	O
transesophageal	transesophageal	JJ	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
high	high	JJ	I-NP	O
risk	risk	NN	I-NP	O
for	for	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Protonix	Protonix	NNP	B-NP	O
and	and	CC	O	O
all	all	PDT	B-NP	O
his	his	PRP$	I-NP	O
stools	stool	NNS	I-NP	O
were	be	VBD	B-VP	O
guaiaced	guaiace	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
p.r.n.	p.r.n.	NN	B-NP	O
Colace	Colace	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
Lantus	Lantus	NNP	I-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
36	36	CD	I-NP	O
units	unit	NNS	I-NP	O
nightly	nightly	RB	B-ADVP	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
level	level	NN	I-NP	O
required	require	VBD	B-VP	O
no	no	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
slightly	slightly	RB	I-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
above	above	IN	B-PP	O
his	his	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
1.9	1.9	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.1	1.1	CD	B-NP	O
to	to	TO	I-NP	O
1.3	1.3	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	B-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADVP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
and	and	CC	I-NP	O
poor	poor	JJ	I-NP	O
forward	forward	JJ	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
decreased	decrease	VBD	B-VP	O
to	to	TO	B-PP	O
1.4	1.4	CD	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
elevation	elevation	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Losartan	Losartan	NNP	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
held	hold	VBN	I-VP	O
while	while	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

GU	GU	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
BPH	BPH	NN	B-NP	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	O
catheter	catheter	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
inserted	insert	VBN	I-VP	O
in	in	IN	B-PP	O
4/10	4/10	CD	B-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
difficulty	difficulty	NN	B-NP	O
to	to	TO	B-VP	O
pass	pass	VB	I-VP	O
Foley	Foley	NNP	B-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
clamped	clamp	VBN	I-VP	O
and	and	CC	O	O
post-void	post-void	JJ	B-NP	O
residuals	residual	NNS	I-NP	O
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
only	only	RB	B-NP	O
50	50	CD	I-NP	O
mL	mL	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
urinating	urinate	VBG	I-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
with	with	IN	B-PP	O
tube	tube	NN	B-NP	O
clamped	clamp	VBD	B-VP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
Urology	Urology	NNP	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
suprapubic	suprapubic	JJ	B-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

Suprapubic	Suprapubic	JJ	B-NP	O
wound	wound	NN	I-NP	O
was	be	VBD	B-VP	O
dressed	dress	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sterile	sterile	JJ	I-NP	O
dry	dry	JJ	I-NP	O
dressing	dressing	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	I-NP	O
Electrolytes	Electrolyte	NNS	I-NP	O
and	and	CC	I-NP	O
Nutrition	Nutrition	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
current	current	JJ	I-NP	O
input	input	NN	I-NP	O
and	and	CC	I-NP	O
output	output	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
0.5	0.5	CD	B-NP	O
L	L	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
2L	2L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
twice	twice	RB	B-NP	O
daily	daily	JJ	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
checks	check	NNS	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
his	his	PRP$	B-NP	O
magnesium	magnesium	NN	I-NP	O
above	above	IN	B-PP	O
2	2	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
above	above	IN	B-PP	O
4	4	CD	B-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
arrhythmias	arrhythmia	NNS	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
of	of	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
,	,	,	I-NP	O
2-gm	2-gm	JJ	I-NP	O
sodium	sodium	NN	I-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2	2	CD	I-NP	O
L	L	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
Flovent	Flovent	NN	B-NP	O
and	and	CC	I-NP	O
albuterol	albuterol	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Niferex	Niferex	NNP	B-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
for	for	IN	B-PP	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
mild	mild	JJ	I-NP	O
eosinophilia	eosinophilia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Derm	Derm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
skin	skin	NN	I-NP	O
tear	tear	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
hand	hand	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
neomycin	neomycin	NN	B-NP	O
ointment	ointment	NN	I-NP	O
and	and	CC	O	O
sterile	sterile	JJ	B-NP	O
dry	dry	JJ	I-NP	O
dressing	dressing	NN	I-NP	O
changes	change	NNS	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
daily	daily	RB	I-NP	O
and	and	CC	O	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
PPI	PPI	NN	I-NP	B-protein
.	.	.	O	O

CODE	CODE	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	IN	B-PP	O
THE	THE	DT	B-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
temperature	temperature	NN	B-NP	O
98.7	98.7	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
118-140/60	118-140/60	CD	B-NP	O
-70	-70	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
35-58	35-58	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
18-20	18-20	CD	I-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
94-100	94-100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
L.	L.	NNP	I-NP	O
Weight	Weight	NNP	I-NP	O
96.6	96.6	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
general	general	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	VBZ	B-VP	O
a	a	DT	B-NP	O
quarter	quarter	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
way	way	NN	I-NP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
and	and	CC	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
decreased	decrease	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bases	base	NNS	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lung	lung	NN	I-NP	O
field	field	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
irregularly	irregularly	RB	I-NP	O
irregular	irregular	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
5-6	5-6	CD	B-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
water	water	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
normoactive	normoactive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
present	present	JJ	B-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
obese	obese	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
and	and	CC	I-NP	O
nontender	nontender	JJ	I-NP	O
.	.	.	O	O

Suprapubic	Suprapubic	JJ	B-NP	O
catheter	catheter	NN	I-NP	O
site	site	NN	I-NP	O
is	be	VBZ	B-VP	O
without	without	IN	B-PP	O
purulence	purulence	NN	B-NP	O
or	or	CC	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
shins	shin	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
venous	venous	JJ	I-NP	O
stasis	stasis	NN	I-NP	O
changes	change	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Skin	Skin	NN	B-NP	O
:	:	:	O	O
There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
present	present	VBP	B-VP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
splinter	splinter	NN	I-NP	O
hemorrhages	hemorrhage	NNS	I-NP	O
or	or	CC	O	O
Osler	Osler	NNP	B-NP	O
nodes	node	NNS	I-NP	O
noted	note	VBD	B-VP	O
.	.	.	O	O

LABS	LABS	NN	B-NP	O
AT	AT	NN	I-NP	O
TIME	TIME	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
141	141	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.0	4.0	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
108	108	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
26	26	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
41	41	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.5	1.5	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
164	164	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.1	9.1	CD	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
2.0	2.0	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
29.2	29.2	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8.9	8.9	CD	B-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-protein
227	227	CD	B-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.1	1.1	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
38.1	38.1	CD	I-NP	I-protein
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
68	68	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
18	18	CD	B-NP	O
%	%	NN	I-NP	O
lymphocytes	lymphocyte	NNS	I-NP	O
,	,	,	O	O
7.1	7.1	CD	B-NP	O
%	%	NN	I-NP	O
monocytes	monocyte	NNS	I-NP	B-cell_type
and	and	CC	O	O
5.9	5.9	CD	B-NP	O
%	%	NN	I-NP	O
eosinophils	eosinophil	NNS	I-NP	B-cell_type
.	.	.	O	O

Gentamicin	Gentamicin	NN	B-NP	O
peak	peak	NN	I-NP	O
is	be	VBZ	B-VP	O
17.8	17.8	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
trough	trough	NN	I-NP	O
of	of	IN	B-PP	O
0.9	0.9	CD	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
once	once	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
nebulizer2	nebulizer2	NN	I-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBD	B-VP	O
q.	q.	NN	B-NP	O
6	6	CD	I-NP	O
h.	h.	NN	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
wheezing	wheezing	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Albuterol	Albuterol	NNP	B-NP	O
nebulizer	nebulizer	IN	B-PP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBD	B-VP	O
q.	q.	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
h.	h.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Dulcolax	Dulcolax	IN	B-PP	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Ceftriaxone	Ceftriaxone	NN	B-NP	O
2000	2000	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
daily	daily	JJ	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
until	until	IN	B-PP	O
8/20/07	8/20/07	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Gentamicin	Gentamicin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
daily	daily	JJ	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
until	until	IN	B-PP	O
7/25/07	7/25/07	CD	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Fluticasone	Fluticasone	NN	B-NP	O
nasal	nasal	JJ	I-NP	O
spray	spray	NN	I-NP	O
one	one	CD	B-NP	O
spray	spray	NN	I-NP	O
in	in	IN	B-PP	O
each	each	DT	B-NP	O
nostril	nostril	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Flovent	Flovent	NN	B-NP	O
110	110	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
5000	5000	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
36	36	CD	I-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Lispro	Lispro	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
a.c.	a.c.	RB	I-ADVP	O
14	14	CD	B-NP	O
.	.	.	O	O

K-Dur	K-Dur	NN	B-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

Niferex	Niferex	NNP	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Pantoprazole	Pantoprazole	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
12	12	CD	I-NP	O
h.	h.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

MiraLax	MiraLax	NN	B-NP	O
17	17	CD	I-NP	O
gm	gm	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Sarna	Sarna	NNP	B-NP	O
topical	topical	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
used	use	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
itching	itch	VBG	B-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
two	two	CD	I-NP	O
tablets	tablet	NNS	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Bacitracin	Bacitracin	NN	B-NP	O
ointment	ointment	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
applied	apply	VBN	I-VP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
hand	hand	NN	I-NP	O
lesion	lesion	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
are	be	VBP	B-VP	O
two	two	CD	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
that	that	WDT	B-NP	O
are	be	VBP	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
to	to	TO	B-PP	O
date	date	NN	B-NP	O
but	but	CC	O	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
PLANS	PLANS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
basic	basic	JJ	I-NP	O
metabolic	metabolic	JJ	I-NP	O
panel	panel	NN	I-NP	O
checked	check	VBD	B-VP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
IS	IS	VBZ	B-VP	O
actively	actively	RB	I-VP	O
diuresing	diurese	VBG	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
basic	basic	JJ	B-NP	O
metabolic	metabolic	JJ	I-NP	O
panel	panel	NN	I-NP	O
checked	check	VBD	B-VP	O
at	at	IN	B-NP	O
least	least	JJS	I-NP	O
twice	twice	RB	I-NP	O
weekly	weekly	JJ	I-ADJP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
electrolytes	electrolyte	NNS	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
draw	draw	VB	I-VP	O
a	a	DT	B-NP	O
CBC	CBC	NN	I-NP	B-protein
with	with	IN	B-PP	O
differential	differential	JJ	O	O
at	at	IN	B-ADVP	O
least	least	JJS	I-ADVP	O
once	once	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
while	while	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
gentamicin	gentamicin	NN	B-NP	O
and	and	CC	I-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
draw	draw	VB	I-VP	O
a	a	DT	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
trough	trough	NN	I-NP	O
once	once	RB	B-ADVP	O
weekly	weekly	RB	I-ADVP	O
and	and	CC	O	O
adjust	adjust	JJ	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
doses	dose	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
consultant	consultant	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
whether	whether	IN	B-SBAR	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
gentamicin	gentamicin	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
beyond	beyond	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
surveillance	surveillance	NN	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
completing	complete	VBG	B-VP	O
antibiotic	antibiotic	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
to	to	TO	B-PP	O
document	document	NN	B-NP	O
clearance	clearance	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
place	place	NN	I-NP	O
neomycin	neomycin	NN	I-NP	O
ointment	ointment	NN	I-NP	O
to	to	TO	B-PP	O
right	right	JJ	B-NP	O
hand	hand	NN	I-NP	O
lesion	lesion	NN	I-NP	O
daily	daily	JJ	I-NP	O
and	and	CC	I-NP	O
cover	cover	JJ	I-NP	O
with	with	IN	B-PP	O
sterile	sterile	JJ	B-NP	O
dry	dry	JJ	I-NP	O
dressings	dressing	NNS	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
dry	dry	JJ	I-NP	O
sterile	sterile	NN	I-NP	O
dressing	dress	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
suprapubic	suprapubic	JJ	I-NP	B-DNA
catheter	catheter	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
to	to	TO	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
daily	daily	RB	B-ADVP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
wound	wound	NN	I-NP	O
is	be	VBZ	B-VP	O
healed	heal	VBN	I-VP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
repeat	repeat	NN	B-NP	O
urine	urine	NN	I-NP	O
cultures	culture	NNS	I-NP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
after	after	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
to	to	TO	B-VP	O
document	document	VB	I-VP	O
clearance	clearance	NN	B-NP	O
of	of	IN	B-PP	O
pseudomonal	pseudomonal	JJ	B-NP	O
UTI	UTI	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Would	Would	MD	B-VP	O
hold	hold	VB	I-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
restarting	restart	VBG	B-VP	O
Losartan	Losartan	NN	B-NP	O
until	until	IN	B-SBAR	O
gentamicin	gentamicin	NN	B-NP	O
is	be	VBZ	B-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
all	all	DT	B-NP	O
pending	pende	VBG	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
.	.	.	O	O

FOLLOWUP	FOLLOWUP	NN	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Appointment	Appointment	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Owen	Owen	NNP	I-NP	O
Cuthbert	Cuthbert	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
Tauscack	Tauscack	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
9/5/07	9/5/07	CD	B-NP	O
at	at	IN	B-PP	O
8	8	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
96.7	96.7	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weight	weight	NN	I-NP	O
is	be	VBZ	B-VP	O
approximately	approximately	RB	B-NP	O
93	93	CD	I-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	O	O
In	In	NNP	B-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
Out	Out	NNP	B-NP	O
goals	goal	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
-500	-500	CD	B-NP	O
cc	cc	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
3-9926453	3-9926453	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
STRATMAN	STRATMAN	NN	B-NP	O
,	,	,	O	O
OSVALDO	OSVALDO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MONEY	MONEY	NNP	B-NP	O
,	,	,	O	O
JEREMY	JEREMY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
1243764	1243764	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/10/07	3/10/07	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/10/07	3/10/07	CD	B-NP	O

